Please login to the form below

Not currently logged in
Email:
Password:

Pollen

This page shows the latest Pollen news and features for those working in and with pharma, biotech and healthcare.

Positive mid-stage trial gives Allergy’s investors some welcome relief

Positive mid-stage trial gives Allergy’s investors some welcome relief

PQ) grass pollen programme on clinical hold after a patient reported numbness and weakness after taking the drug. ... Around 30% of the population in Europe and  a quarter of Americans are allergic to grass pollen.

Latest news

  • GSK sets its sights high for MyAsthma app GSK sets its sights high for MyAsthma app

    behaviours. The app also provides metrics such as the pollution index and current pollen count to give users notice of any problems they might have.

  • Digital technology and patient support Digital technology and patient support

    For instance, MyAsthma, from GlaxoSmithKline, which is a personalised adherence programme that uses data to give advice on the environmental levels of pollution and pollen in the area to reduce exacerbating

  • St Ives buys Hive St Ives buys Hive

    The group operates across three main divisions: Hive, its strategic healthcare consultancy and communications business, Pollen, a strategic medical communications consultancy, and eBee, a specialist digital healthcare agency.

  • Merck gets US green light for allergy immunotherapy Merck gets US green light for allergy immunotherapy

    Merck &Co and Alk-Abello have been given the go-ahead by the US FDA to start selling their grass pollen allergy immunotherapy Grastek. ... The US regulator approved Grastek for the treatment of Timothy grass pollen-induced allergic rhinitis with or

  • FDA backs a brace of allergy immunotherapies FDA backs a brace of allergy immunotherapies

    Oralair includes allergen extracts from mixed pollens comprising sweet vernal, orchard, perennial rye, Timothy, and Kentucky blue grass, while Grastek contains timothy grass pollen only. ... range. Even at the top end that would correspond to a minor

More from news
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Allergies and asthma Allergies and asthma

    AIT with birch or grass pollen had a long-lasting preventive effect on asthma, up to seven years after the treatment was stopped.

  • Country report: The healthcare market in China Country report: The healthcare market in China

    Health Alerts. Weather (common cold/influenza). Pollen counts (allergies). Pollution (asthma). In response to the changing needs of the consumer, healthcare companies have embarked on building the necessary digital platforms to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • ROCK names new managing director ROCK names new managing director

    ROCK names new managing director. Terence Bradley was previously founding director of Pollen Health. ... ROCK medical communications has named founding director of Pollen Health Terence Bradley as its new managing director.

  • Ben Fisher to lead Hive's med ed agency Ben Fisher to lead Hive's med ed agency

    Ben Fisher to lead Hive's med ed agency. He joins Pollen from Ogilvy Healthworld. ... The Hive Group has appointed Ben Fisher as head of Pollen, its London-based medical education agency.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics